Literature DB >> 24640991

Analgesic efficacy of opioids in chronic pain: recent meta-analyses.

H Reinecke1, C Weber, K Lange, M Simon, C Stein, H Sorgatz.   

Abstract

UNLABELLED: Opioids are regularly administered in acute and cancer pain. In chronic non-cancer pain (CNCP), however, their use is controversial. Previous meta-analyses and randomized controlled trials (RCTs) lack methodological homogeneity and comparable data. Here we analysed the maximum analgesic efficacies of opioids and non-opioids compared with placebo, and of physiotherapy and psychotherapy compared with active or waiting-list controls. We screened 3647 citations and included RCTs if treatment duration was at least 3 weeks, data were sufficient for meta-analysis, and criteria for high quality were met. Only 46 studies (10 742 patients) met the criteria. Weighted and standardized mean differences (WMD, SMD) between pain intensities were pooled to conduct separate meta-analyses for each treatment category. At the end of treatment the WMD for pain reduction (100-point scale) was 12.0 for 'strong' opioids, 10.6 for 'weak' opioids, 8.4 for non-opioids (each vs. placebo), 5.5 for psychotherapy and 4.5 for physiotherapy (each vs. active controls). Dropout rates were high in pharmacological studies. The 95% confidence intervals using the outcomes of control groups did not indicate statistical differences between efficacies of the five interventions. Because not enough eligible head-to-head trials were available, our analysis is limited to adjusted indirect comparisons. The heterogeneity of pre-post pain differences in control groups did not allow the definition of a common comparator. In conclusion, although there were statistically significant differences between maximum treatment efficacies, no intervention per se produced clinically important improvements in average pain intensity. Thus, opioids alone are inappropriate and multimodal treatment programmes may be required for CNCP. LINKED ARTICLES: This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2.
© 2014 The British Pharmacological Society.

Entities:  

Keywords:  Chronic pain; NSAID; non-cancer pain; non-malignant pain; nonsteroidal anti-inflammatory drugs; opioids; physiotherapy; psychotherapy

Mesh:

Substances:

Year:  2014        PMID: 24640991      PMCID: PMC4292950          DOI: 10.1111/bph.12634

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  54 in total

Review 1.  Attacking pain at its source: new perspectives on opioids.

Authors:  Christoph Stein; Michael Schäfer; Halina Machelska
Journal:  Nat Med       Date:  2003-08       Impact factor: 53.440

2.  Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors.

Authors:  An-Wen Chan; Douglas G Altman
Journal:  BMJ       Date:  2005-01-28

Review 3.  Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.

Authors:  Bridget A Martell; Patrick G O'Connor; Robert D Kerns; William C Becker; Knashawn H Morales; Thomas R Kosten; David A Fiellin
Journal:  Ann Intern Med       Date:  2007-01-16       Impact factor: 25.391

4.  Adherence and long-term effect of oxycodone/paracetamol in chronic noncancer pain: a retrospective study.

Authors:  Antonio Gatti; Massimo Mammucari; Elisabetta Sabato; Loredana Masucci; Alessandro Fabrizio Sabato
Journal:  Adv Ther       Date:  2011-04-08       Impact factor: 3.845

Review 5.  Treatment of chronic non-cancer pain.

Authors:  Dennis C Turk; Hilary D Wilson; Alex Cahana
Journal:  Lancet       Date:  2011-06-25       Impact factor: 79.321

Review 6.  A qualitative systematic review of head-to-head randomized controlled trials of oral analgesics in neuropathic pain.

Authors:  C Peter N Watson; Ian Gilron; Jana Sawynok
Journal:  Pain Res Manag       Date:  2010 May-Jun       Impact factor: 3.037

7.  A population-based survey of chronic pain and its treatment with prescription drugs.

Authors:  Robin L Toblin; Karin A Mack; Ghazala Perveen; Leonard J Paulozzi
Journal:  Pain       Date:  2011-03-11       Impact factor: 6.961

8.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

Review 9.  Grey literature in meta-analyses of randomized trials of health care interventions.

Authors:  S Hopewell; S McDonald; M Clarke; M Egger
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

10.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

View more
  21 in total

Review 1.  [Research consortium Neuroimmunology and pain in the research network musculoskeletal diseases].

Authors:  H-G Schaible; H-D Chang; S Grässel; H Haibel; A Hess; T Kamradt; A Radbruch; G Schett; C Stein; R H Straub
Journal:  Z Rheumatol       Date:  2018-05       Impact factor: 1.372

Review 2.  Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit.

Authors:  Adeleke D Adewumi; Christine E Staatz; Samantha A Hollingworth; Jason P Connor; Rosa Alati
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

3.  Themed section.

Authors:  M J Christie; M Connor; J R Traynor
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

4.  The Effect of Transcranial Direct Current Stimulation on Inflammation in Older Adults With Knee Osteoarthritis: A Bayesian Residual Change Analysis.

Authors:  Robert Suchting; Gabriela D Colpo; Natalia P Rocha; Hyochol Ahn
Journal:  Biol Res Nurs       Date:  2019-08-15       Impact factor: 2.522

5.  Drug-gene and drug-drug interactions associated with tramadol and codeine therapy in the INGENIOUS trial.

Authors:  Cathy R Fulton; Yong Zang; Zeruesenay Desta; Marc B Rosenman; Ann M Holmes; Brian S Decker; Yifei Zhang; John T Callaghan; Victoria M Pratt; Kenneth D Levy; Brandon T Gufford; Paul R Dexter; Todd C Skaar; Michael T Eadon
Journal:  Pharmacogenomics       Date:  2019-02-20       Impact factor: 2.533

Review 6.  [Pain inhibition by opioids-new concepts].

Authors:  C Stein
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

7.  Synergistic regulation of serotonin and opioid signaling contributes to pain insensitivity in Nav1.7 knockout mice.

Authors:  Jörg Isensee; Leonhardt Krahé; Katharina Moeller; Vanessa Pereira; Jane E Sexton; Xiaohui Sun; Edward Emery; John N Wood; Tim Hucho
Journal:  Sci Signal       Date:  2017-01-10       Impact factor: 8.192

8.  Association between pain, anxiety, and pain relief in patients receiving emergent endodontic treatment.

Authors:  Long-Ting Wu; Chia-Shu Lin; Shue-Fen Yang
Journal:  Clin Oral Investig       Date:  2021-06-02       Impact factor: 3.573

9.  Eye Movement Desensitization and Reprocessing vs. Treatment-as-Usual for Non-Specific Chronic Back Pain Patients with Psychological Trauma: A Randomized Controlled Pilot Study.

Authors:  Andreas Gerhardt; Sabine Leisner; Mechthild Hartmann; Susanne Janke; Günter H Seidler; Wolfgang Eich; Jonas Tesarz
Journal:  Front Psychiatry       Date:  2016-12-20       Impact factor: 4.157

Review 10.  Neuropathic low back pain in clinical practice.

Authors:  R Baron; A Binder; N Attal; R Casale; A H Dickenson; R-D Treede
Journal:  Eur J Pain       Date:  2016-03-02       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.